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ABSTRACT: Halogenation is reported as an approach to tune 
amyloidogenic peptide self-assembly. Seven halogenated 
derivatives of the pentapeptide KLVFF show supramolecular 
polymorphism, affording peptide nanoparticles, ‘cotton balls’, 
straight tapes, twisted or helical ribbons according to position, 
nature and number of the introduced halogen atoms. Our 
findings demonstrate that halogenation may represent a general 
strategy to modulate peptide self-assembly and design new 
amyloidal assemblies. 
Alongside pathological roles in many diseases, e.g., 
Alzheimer’s, Parkinson’s, Creutzfeldt-Jacob, and Huntington’s,1 
amyloid peptide architectures have found many other 
nonbiological applications2 as forming highly ordered 
nanomaterials.3 Together with their biocompatibility and ease of 
production,4 amyloidogenic peptides show a very versatile 
polymorphic behavior yielding a broad range of hierarchical 
structures, such as tapes, ribbons, fibers, nanoparticles, and 
nanotubes.5,6 Subtle variations in the experimental conditions, 
peptide sequence or its chemical functionalization may impact 
the self-assembly pathway and, consequently, the resulting 
nanostructure.7  
Despite representing a powerful tool to produce various 
nanoobjects, amyloid intrinsic polymorphism may, however, 
limit the controlled construction of specifically designed 
nanostructures. The possibility of tuning such polymorphic 
behavior is still in its early stages.8,9 For example, amino acid 
sequence in constitutionally isomeric tetrapeptide amphiphiles 
has recently been shown to dictate nanostructural architecture.10 
Chemical functionalization of the peptide sequence has also 
been demonstrated to be a powerful tool for controlling amyloid 
self-assembly.11,12 In this regard, polymer conjugation has 
extensively been studied as a particularly fruitful strategy.13  
Recently, some of us demonstrated that halogenation at the p-
position of one or both phenylalanine (Phe) benzene rings of the 
human calcitonin-derived fibrillogenic peptide sequence 
DFNKF,14 promotes amyloid self-assembly. Hydrogel 
formation efficiency is also promoted by the rich variety of 
noncovalent interactions given by halogen atoms,15 among 
these, the halogen bond.16 In this context, here we applied this 
strategy to dictate the  
 
Figure 1. Chemical structures of halogenated KLVFF peptides. 
architectures of the obtained amyloid nanostructures starting 
from the amyloid β (Aβ) peptide-derived core-sequence KLVFF 
(H2N-Lys-Leu-Val-Phe-Phe-COOH) (Figure 1). Thanks to the 
presence of the –FF– motif, this pentapeptide has a highly 
pronounced aggregation propensity, as proved both 
computationally17-19 and experimentally.20   
By single-atom hydrogen-for-halogen replacement at the p-
position of either one or both Phe benzene rings of KLVFF, we 
demonstrate here that halogenation dictates controlled formation 
of various nanostructures. Nanoparticles, ribbons, fibrils, and 
“cotton balls” are specifically obtained depending on the 
number, position, and nature of the introduced halogen atoms. 
This is remarkable for such a modest chemical structure 
modification. These results reveal the potential of controlling 
the morphology of amyloid nanostructures through single-point 
halogenation of amino acid sequence. 
To study the effect of the introduction of halogen atoms at 
speciﬁc positions of the KLVFF pentapeptide on its self-
 assembly, we obtained the 4-p-X-Phe derivative, the 5-p-X-Phe 
derivative, as well as the 4,5-bis-p-X-Phe derivative, where X = 
I, Br, Cl, H (Figure 1). Importantly, all of the studied peptides 
carry free amino (N) and carboxyl (C) termini. 
Aqueous samples of the peptides were prepared by direct 
dispersion in milli-Q water (see Supporting Information, SI). As 
an indication of the formation of fibrils,19 hydrogelation tests 
were run and minimum gelation concentrations (MGCs) 
determined. KLVF(I)F, KLVF(Br)F, and KLVF(I)F(I) were 
found to form gels (Figure 2) above MGCs that were much  
 
Figure 2. 15 mM peptide water samples upon aging 48h at r.t. 
lower than the wild-type fragment KLVFF (60 mM) (Table 
S1).20 The best gelator of the series, KLVF(I)F, showed an 
MGC of 7 mM (0.5 % w/w, i.e., 8-fold lower than KLVFF). 
This already indicates that halogenation has a clear effect on the 
peptide self-assembly process, promoting fibrillation, as 
previously observed.14 A working concentration of 15 mM was 
chosen to compare all the gel-forming halogenated peptides in 
the same conditions (Table S2). The efficiency of gel formation 
in these conditions followed the order KLVF(I)F > KLVF(Br)F 
> KLVF(I)F(I). The first two mono-halogenated peptides 
yielded homogeneous and transparent gels. The bis-iodinated 
one, instead, formed a homogeneously opaque, off-whitish 
(“milky”), gel.  
Characterization of the different halogenated peptide 
hydrogels was done by oscillatory rheology (ring-cast method) 
using the 15 mM concentration samples. The mono-iodinated 
peptide was conﬁrmed to form the stiffest gel, which is reﬂected 
in its higher elastic modulus (G’ ̴ 103 Pa and G’’ ̴ 102 Pa after 
two weeks aging; Figure S1 in the SI). The trends of G’ and G’’ 
values parallel that of gel formation efﬁciency and MGCs, i.e., 
KLVF(I)F > KLVF(Br)F > KLVF(I)F(I). In particular, the 
latter yielded the weakest gel, which turned stiff enough for 
rheological measurement only after 2-week aging. 
All other peptides, i.e., WT, KLVFF(I), KLVFF(Br), 
KLVF(Br)F(Br) and KLVF(Cl)F(Cl) did not form gels in the 
same experimental set-up and all but KLVF(Br)F(Br) afforded 
colorless solutions. KLVF(Br)F(Br), instead, formed a 
homogeneously opaque, “milky” solution.  
Interestingly, the pairs KLVF(I)F – KLVFF(I) and 
KLVF(Br)F – KLVFF(Br) are constitutional isomers though 
show dramatically different macroscopic behavior (gels vs. 
solutions), highlighting the specific role of the position of the 
halogen atom in the peptide sequence. Furthermore, the different 
behavior of KLVF(I)F(I) compared to KLVF(Br)F(Br) also 
highlights a potential role of halogen atom polarizability in the 
self-assembly process. Hydrophobic interactions should not play 
a major role in determining the observed 15 mM-solution 
behaviors, e.g., hydrogel formation,21 because mono-
halogenated peptides have similar hydrophobicity, and the bis-
brominated derivative is more hydrophobic than the mono-
halogenated ones (Table S3). Also, electrostatic interactions 
cannot fully explain differences between the studied peptides. 
The “milky” solution given by the KLVF(Br)F(Br) peptide 
was analyzed by using Polarized Optical Microscopy (POM) at 
room temperature. Birifringent textures were observed after 48 
hour from preparation (Figure S2), indicating that at a 15 mM 
concentration, KLVF(Br)F(Br) self-assembles into lyotropic 
liquid  crystalline phases at r.t. In particular, the observed 
textures, i.e., Maltese crosses, are characteristic of smectic A 
phases, which indicate a lamellar-type organization. 
In order to investigate whether different solution behavior is 
related to a different morphology of the halogenated peptide 
assemblies, imaging was performed using Transmission 
Electron Microscopy (TEM; 15 mM, 48h after preparation) 
(Figure 3). 
Figure 3. TEM images of 15 mM dried gels/solutions of the 
halogenated derivatives of KLVFF showing different 
architectures upon varying position, number, and nature of the 
halogen atoms. 
As expected, the peptides forming the strongest gels – 
KLVF(I)F and KLVF(Br)F – showed a dense network of 
entangled fibrils (Figure 3a,c), which is rather usual for 
amyloidal hydrogels. The weakest gel-forming peptide 
KLVF(I)F(I), instead, formed an entangled network of ribbon-
like fibers, either straight or twisted, which may explain the 
“milky” appearance of the gel due to light scattering (Figure 
3b). A few long, thin, and straight fibrils were also observed in 
the case of KLVF(Cl)F(Cl), which, however, do not lead to the 
formation of the dense and entangled network needed for gel 
formation (Figure 3d). 
The non- gel-forming peptides KLVFF(I) and 
KLVF(Br)F(Br) showed the most interesting morphologies. In 
particular, spherical nanoparticles (NPs) of around 50 nm were 
observed for the former (Figure 4a), while spherical structures ( ̴ 
300 nm) having a fuzzy, hairy, interface, here referred as 
“cotton balls” were observed for the latter in freshly prepared 
samples (Figure 4d). These aggregates are likely to act as 
nucleation centers for the undeveloped fibril structures 
branching out, but do not develop into a proper hydrogel 
network. Derivative KLVFF(Br) and WT peptides, instead, 
only formed amorphous aggregates (Figure S3). Overall, 
obtained TEM data clearly indicated the possibility of 
engineering different amyloid fibril architectures by changing 
position, number, and nature of the halogen atoms in the peptide 
fragment KLVFF. 
Due to their interesting morphologies and to ascertain 
whether the observed peptide nanostructures may be related to 
drying effects, vitrified 15 mM aqueous solutions of KLVFF(I) 
and KLVF(Br)F(Br) were furtherly investigated by Cryogenic-
TEM  (Cryo-TEM). As shown in Figure 4a1, the presence of the 
 spherical NPs observed in the dried state was confirmed for 
sample KLVFF(I). Imaged NPs showed smoother interface and 
more uniform shape when compared to NPs imaged in the dried 
state, indicating a possible NP agglomeration effect during the
Figure 4. a) TEM image of 15 mM dried sample of KLVFF(I) aged for 48h; a1) Cryo-TEM image showing the spherical nanoparticles 
formed by KLVFF(I) 15 mM; b) SAXS profile of 15 mM KLVFF(I) dispersion with fitting analysis according to a core-shell spherical 
form factor; c) Number average size distribution extracted from DLS analysis of KLVFF(I) 5 mM dispersion; d) TEM image of 15 mM 
dried sample of KLVF(Br)F(Br) aged for 48h; d1) Magnification of an isolated “cotton ball” structure formed by KLVF(Br)F(Br) from 
15 mM solution aged for a week; e) Cryo-TEM image showing an entangled fibrillar network formed by a one-month aged 
KLVF(Br)F(Br) 15 mM sample; f) SAXS profile of KLVF(Br)F(Br) 15 mM samples with fitting analysis according to a bilayer form 
factor. 
state. A 5 mM water dispersion of KLVFF(I) was also studied 
by multi-angle DLS analysis giving bimodal auto-correlation 
functions composed of two populations characterized by 50 nm 
and 330 nm hydrodynamic radius, respectively (Figure S4). 
However, the number-averaged size distribution obtained for the 
same sample showed that the small population is much more 
abundant than the larger one, which is in agreement with 
microscopy results (Figure 4c). 
On the other hand, cryo-TEM imaging of individual “cotton 
balls” formed by freshly prepared samples of KLVF(Br)F(Br) 
was not achievable as the maximum thickness detectable with 
this technique is about 100 nm (Figure S10).22 However, cryo-
TEM analysis on one-month aged solutions indicated the 
presence of an entangled network of fibers with well visible 
nucleation points (Figure 4e), suggesting that the “cotton balls” 
evolved in a more thermodynamically stable architecture such 
as the typical amyloid fibril network. This structural transition is 
also observable macroscopically, since freshly prepared 15 mM 
peptide solutions become more and more viscous over time until 
they form a gel (Figure S11). 
Bulk characterization of one-month aged 15 mM peptide 
samples was carried out through Small Angle X-Ray Scattering 
(SAXS) (Figure S12). Halogenated derivatives showed a clearly 
different scattering behavior compared to KLVFF. Bragg Peaks 
at q = 1.5 nm-1 can be seen for samples KLVF(Br)F(Br) (Figure 
4f) and  KLVF(I)F(I) (Figure S12), indicating the presence of 
periodic structures with around 2 nm spacing. Scattering 
patterns for these two samples were fitted using a bilayer model, 
previously employed for tape/ribbon-like structures.23 Obtained 
values indicate a bilayer thickness of 1.4 nm for the bis-
brominated peptide and 0.9 nm for the bis-iodinated one. 
KLVFF(I) scattering curve was fitted by a core-shell spherical 
model (Figure 4b). The fitting yielded a diameter of 19.1 nm, in 
good agreement with size determined by cryo-TEM. Long 
cylindrical shell model was, instead, used to analyze 
KLVFF(Br) scattering curve (Figure S12). The fitting indicated 
a cylinder diameter of 5.7 nm. 
  
Figure 5. ‘Steric zipper’ motif formed by KLVF(I)F(I), 
showing intermolecular halogen bonds among the iodine atom 
and the carbonyl oxygen belonging to adjacent β-sheets. 
We have recently demonstrated that iodination, alongside 
facilitating phase determination, may be developed as a routine 
strategy to obtain the single-crystal X-ray structures of peptide 
segments otherwise difficult to crystallize. Thanks to this 
strategy, we have, for example, shed light on the elusive 
aromatic–aromatic interactions occurring in peptide segments 
containing phenylalanine, such as DFNKF24. With the objective 
of determining whether noncovalent interactions involving 
halogen atoms may play a role in stabilizing the nanostructures 
observed in the present studies, we attempted crystallization of 
the KLVF(I)F(I) derivative. Small, weakly diffracting, and 
poorly ordered crystals were obtained after two months 
upon slow evaporation of a water/hexafluoro-2-propanol 9:1 
mixture (see SI). However, accurate structure solution was 
possible by using synchrotron radiation. 
Similar to all other amyloid structures, the stacking of β-sheet 
pairs at the dry interface is the stable structural unit of the 
“cross-β-spine”,25 along which tightly interacting side chains 
form the self-complementary motif called “steric zipper”,26 
which explains how very short peptide sequences are able to 
form such extended structures like amyloid fibrils (Figure S14). 
Interestingly, the high-resolution single-crystal structure of 
KLVF(I)F(I) shows the occurrence of intermolecular C=O···I 
contacts, i.e., halogen bonds, between peptides belonging to 
adjacent β-sheets (Figure 5). The two asymmetric O···I 
distances are O_1···I_5 3.34(3) Å and O_2···I_4 3.43(3) Å, 
with C=O···I and O···I-C angles of 111(2)° and 103(2)°, and 
165(1)° and 159(1)°, respectively. Importantly, the O_2···I_4 
halogen bond occurs orthogonally27 to the O_2···N_3 hydrogen 
bond of the β-sheet (N···O distance 2.99(3) Å; N···O···I angle 
88.5(8)°). This is the first structural evidence of halogen 
bonding stabilizing the steric zipper of amyloidogenic peptides. 
The occurrence of halogen bonding causes KLVF(I)F(I) 
monomers to pair in parallel mode, while in the structure of the 
non-iodinated sequence KLVFFA, monomers pair in 
antiparallel mode, resulting in a different type of “steric 
zipper”(Figure S14). This result confirms the potential that the 
halogen bond has to engineer amyloidal peptide self-assembly.14 
The high-resolution single-crystal structures of 
KLVF(Br)F(Br) and KLVF(Cl)F(Cl) were also obtained. The 
former is isostructural with KLVF(I)F(I) and shows a weaker 
halogen bonding, due to the lower polarizability of Br, while the 
latter shows no sign of halogen bonding as can be expected from 
a chlorobenzene derivative.16 
In conclusion, herein we have reported that single-atom 
hydrogen-for-halogen replacement at the p-position of either 
one or both Phe benzene rings expands the structural landscape 
of KLVFF. At least four solution-stable polymorphic 
architectures have been obtained comprising fibrils, ribbons, 
nanoparticles, and “cotton balls”, which are not shown by the 
WT peptide in the same experimental conditions. The position, 
nature, and number of the introduced halogen atoms dictate the 
specific formation of each determined architecture. The present 
hypothesis is corroborated by crystallographic determinations 
that fully demonstrate the potential that halogen bond has to 
engineer amyloidal peptide self-assembly.  
ASSOCIATED CONTENT  
Supporting Information 
Experimental procedures, additional tables and figures. This 
material is available free of charge via the Internet at 
http://pubs.acs.org. 
Supplementary material. CCDC 1454960, 1454959, and 
1494096 contain the supplementary crystallographic data for 
peptides KLVF(I)F(I), KLVF(Br)F(Br), and KLVF(Cl)F(Cl), 
respectively. These data can be obtained free of charge from the 
Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
AUTHOR INFORMATION 
Corresponding Author 
* pierangelo.metrangolo@polimi.it  
Author Contributions 
The manuscript was written through contributions of all authors. 
All authors have given approval to the final version of the 
manuscript. 
Funding Sources 
The European Research Council (ERC) is acknowledged for the 
granting the project FOLDHALO to P.M. (no. 307108). IWH 
thanks EPSRC (UK) for Platform grant ref. EP/L020599/1 and 
the ESRF for the award of beamtime (ref. MX-1769) 
REFERENCES 
(1) Chiti, F.; Dobson, C. M. Annu. Rev. Biochem 2006, 75, 333. 
(2) Ulijn, R. V.; Smith, A. M. Chem. Soc. Rev. 2008, 37, 664. 
(3) Cherny, I.; Gazit, E. Angew. Chemie - Int. Ed. 2008, 47, 4062. 
(4) Branco, M. C.; Schneider, J. P. Acta Biomater. 2009, 5, 817. 
(5) Aggeli, A.; Nyrkova, I. A.; Bell, M.; Harding, R.; Carrick, L.; 
McLeish, T. C. B.; Semenov, A. N.; Boden, N. Proc. Natl. Acad. Sci. 
U.S.A. 2001, 98, 11857. 
(6) Hamley, I. W. Angew. Chemie - Int. Ed. 2014, 53, 6866. 
(7) Caplan, M. R.; Schwartzfarb, E. M.; Zhang, S.; Kamm, R. D.; 
Lauffenburger, D. A. Biomaterials 2002, 23, 219. 
(8) Elkins, M. R.; Wang, T.; Nick, M.; Jo, H.; Lemmin, T.; Prusiner, S. 
B.; Degrado, W. F.; Stöhr, J.; Hong, M. J. Am. Chem. Soc. 2016, 138, 
9840. 
(9) Berryman, J. T.; Radford, S. E.; Harris, S. A. Biophys. J. 2011, 100, 
2234. 
(10) Cui, H.; Cheetham, A. G.; Pashuck, E. T.; Stupp, S. I. J. Am. Chem. 
Soc. 2014, 136, 12461. 
(11)Taraballi, F.; Campione, M.; Sassella, A.; Vescovi, A.; Paleari, A.; 
Hwang, W.; Gelain, F.; Soft Matter, 2009, 5, 660. 
 (12)  Wang Y.; Qi W.; Huang R.; Yang X.; Wang M.; Su R.; He Z. J. Am. 
Chem. Soc, 2015, 137, 7869. 
(13) Hamley, I. W.; Krysmann, M. J. Langmuir 2008, 24, 8210-8214. 
(14) Bertolani, A.; Pirrie, L.; Stefan, L.; Houbenov, N.; Haataja, J. S.; 
Catalano, L.; Terraneo, G.; Giancane, G.; Valli, L.; Milani, R.; Ikkala, 
O.; Resnati, G.; Metrangolo, P. Nat. Commun. 2015, 6:7574, DOI: 
10.1038/ncomms8574. 
(15) Metrangolo, P.; Pilati, T.; Resnati, G. CrystEngComm 2006, 8, 946. 
(16) Cavallo, G.; Metrangolo, P.; Milani, R.; Pilati, T.; Priimägi, A.; 
Resnati, G.; Terraneo, G. Chem. Rev., 2016, 116, 2478. 
(17) Gazit, E. Nat. Chem. 2015, 7, 14. 
(18) Frederix, P. W. J. M.; Scott, G. G.; Abul-Haija, Y. M.; Kalafatovic, 
D.; Pappas, C. G.; Javid, N.; Hunt, N. T.; Ulijn, R. V; Tuttle, T. Nat. 
Chem. 2015, 7, 30. 
(19) Steed, J.W. Chem.Commun., 2011, 47, 1379. 
(20) Krysmann, M. J.; Castelletto, V.; Kelarakis, A.; Hamley, I. W.; 
Hule, R. A; Pochan, D. J. Biochemistry 2008, 47, 4597.           
(21) Abbas, M.; Zou, Q.; Li, S.; Yan, X.; Adv. Mater. 2017, 29, 
DOI: 10.1002/adma.201605021. 
(22) Glaeser, R. M. Nat Methods 2016, 13, 28. 
(23) Hamley, I. W; Dehsorkhi, A.; Castelletto, V. Chem. Commun. 2013, 
49, 1850. 
(24) Bertolani, A., Pizzi, A., Pirrie, L., Gazzera, L., Morra, G., Meli, M., 
Colombo, G., Genoni, A., Cavallo, G., Terraneo, G., Metrangolo, P. 
Chem. Eur. J. 2017, 23, 2051. 
(25) Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. Ø.; Riekel, 
C.; Grothe, R.; Eisenberg, D. Nat. Cell Biol. 2005, 435, 773. 
(26) Stroud, J. C. Acta Crystallogr. Sect. D Biol. Crystallogr. 2013, 69, 
540. 
(27) Vasylyeva, V.; Nayak, S. K; Terraneo, G.; Cavallo, G.; Metrangolo, 
P.; Resnati, G. CrystEngComm,2014, 16, 8102. 
 
 
 
